NDRA - Endra Life Sciences GAAP EPS of $0.06 beats by $0.12 August, 15 2022 04:19 PM ENDRA Life Sciences Inc. Endra Life Sciences press release ( NASDAQ: NDRA ): Q2 GAAP EPS of $0.06 beats by $0.12 . Cash and cash equivalents were $11.3 million as of June 30, 2022. For further details see: Endra Life Sciences GAAP EPS of $0.06 beats by $0.12